Comparison of octreotide scintigraphy and conventional imaging in medullary thyroid carcinoma.

Abstract

Somatostatin receptor scintigraphy only demonstrates part of tumor sites and cannot visualize small tumor sites (< or = 1 cm). We believe that somatostatin receptor scintigraphy has a limited role in the management of MTC patients.